Search results
BioMarin Pharmaceutical (NASDAQ:BMRN) shareholders have endured a 15% loss from investing in the...
Simply Wall St. via Yahoo Finance· 12 hours agoIt's easy to match the overall market return by buying an index fund. Active investors aim to buy...
The Biomarin Pharmaceutical Inc (BMRN) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 7 months agoBiomarin Pharmaceutical Inc (NASDAQ:BMRN) has a strong focus on rare-disease therapies, with several...
Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
GuruFocus.com via Yahoo Finance· 1 month agoRobust portfolio of rare-disease therapies with a focus on genetic discovery. Strategic positioning...
BioMarin (BMRN) Q1 Earnings Top, Voxzogo Drives Sales
Zacks via Yahoo Finance· 1 year agoBioMarin (BMRN) reports encouraging first-quarter results, wherein both earnings and sales beat...
An Intrinsic Calculation For BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Suggests It's 45%...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights The projected fair value for BioMarin Pharmaceutical is US$166 based on 2 Stage Free...
BioMarin's (BMRN) Hemophilia Gene Therapy Gets Nod in EU
Zacks via Yahoo Finance· 2 years agoBioMarin's (BMRN) Roctavian is the first gene therapy to get approval for hemophilia A in the...
BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Stock On An Uptrend: Could Fundamentals Be Driving The...
Simply Wall St. via Yahoo Finance· 1 year agoMost readers would already be aware that BioMarin Pharmaceutical's (NASDAQ:BMRN) stock increased...
BioMarin (BMRN) Q3 Earnings Beat, Sales Miss, Ups Voxzogo View
Zacks via Yahoo Finance· 2 years agoBioMarin Pharmaceutical BMRN reported adjusted earnings of 45 cents per share in third-quarter 2022,...
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks via Yahoo Finance· 2 years agoBioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings...
Wall Street Analysts See a 31% Upside in BioMarin (BMRN): Can the Stock Really Move This High?
Zacks via Yahoo Finance· 2 years agoThe mean of analysts' price targets for BioMarin (BMRN) points to a 30.9% upside in the stock. While...